ICG
IBIO icon

InterOcean Capital Group’s iBio IBIO Stock Holding History

InterOcean Capital Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-90
Closed -$8K – 424
2022
Q3 		$8K Hold
90
– – ﹤0.01% 410
2022
Q2 		$12K Hold
90
– – ﹤0.01% 424
2022
Q1 		$19K Hold
90
– – ﹤0.01% 285
2021
Q4 		$25K Hold
90
– – ﹤0.01% 268
2021
Q3 		$48K Buy
90
+10
+13% +$6.23K ﹤0.01% 252
2021
Q2 		$60K Buy
80
+10
+14% +$7.29K ﹤0.01% 255
2021
Q1 		$54K Buy
70
+40
+133% +$34.8K ﹤0.01% 241
2020
Q4 		$16K Buy
+30
New +$24.4K ﹤0.01% 231

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

InterOcean Capital Group's IBIO Position: Q4 2022 in Review

InterOcean Capital Group sold out of iBio (IBIO) in Q4 2022, closing a stake of 90 shares — an estimated $8K sold.

InterOcean Capital Group first reported a position in IBIO in Q4 2020 and held it in 8 quarters. The position peaked at $60K in Q2 2021. 36 funds tracked by Wall St. Rank hold IBIO as of Q4 2022.

  • InterOcean Capital Group reported no remaining iBio position as of Q4 2022 after selling out during the quarter.
  • InterOcean Capital Group sold 90 iBio shares in Q4 2022, an estimated $8K.
  • InterOcean Capital Group first reported a position in iBio in Q4 2020 and held it in 8 quarters.
  • InterOcean Capital Group's iBio position peaked at $60K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held iBio as of Q4 2022.

Based on InterOcean Capital Group's 13F filing for Q4 2022, filed 8 Feb 2023.